Clinical Trials Directory

Trials / Conditions / Neonatal Opioid Withdrawal Syndrome

Neonatal Opioid Withdrawal Syndrome

12 registered clinical trials studyying Neonatal Opioid Withdrawal Syndrome — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingTarget Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
NCT07278375
HELP for NOWS Consortium—
Active Not RecruitingNeurostimulation to Improve NOWS Outcomes
NCT05129020
Spark Biomedical, Inc.N/A
CompletedUse of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.
NCT04834297
Tufts Medical CenterN/A
TerminatedCHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome
NCT04104646
Chiesi Farmaceutici S.p.A.Phase 2
WithdrawnRandomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrom
NCT04455802
Women and Infants Hospital of Rhode IslandPhase 3
Active Not RecruitingTrial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
NCT04214834
Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) ProgramPhase 3
Active Not RecruitingACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study
NCT04149509
Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program—
CompletedMedication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
NCT03911466
T. John Winhusen, PhD—
CompletedMedication Treatment for Opioid Use Disorder in Expectant Mothers
NCT03918850
T. John Winhusen, PhDPhase 3
CompletedOptimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
NCT04298853
Indiana UniversityPhase 4
RecruitingMicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
NCT05937594
Milton S. Hershey Medical Center—
CompletedMaternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
NCT04049799
University of Vermont—